HomeMPHASIS › Filing
🔔 Get instant alerts when MPHASIS files quarterly results on BSE Start free trial →
MphasiS Limited (MPHASIS)

Presentation for Investor/Analyst Call

Filed: 24 Jul 2026, 00:04 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Direct revenue grew 9.9% YoY and 2.2% QoQ, driven by TMT and Retail segments - Strong sequential growth in Americas and Rest of World, led by GCCs - Net new TCV wins at $461 Mn with three large deals including one $100 Mn+ deal - Pipeline expanded 8% QoQ and 28% YoY, supporting growth momentum - Margins stable within 14.75%-15.75% band despite acquisition costs - Q2FY27 expected to deliver best sequential growth in constant currency in 3 years - Targeting high single digit to low double-digit growth and 80% net income to operating cash flow conversion
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MPHASIS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MPHASIS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on MphasiS Limited

Important. The summary above is generated automatically from MphasiS Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.